These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 15325892

  • 1. A phase I comparative postcoital testing study of three concentrations of C31G.
    Mauck CK, Creinin MD, Barnhart KT, Ballagh SA, Archer DF, Callahan MM, Schmitz SW, Bax R.
    Contraception; 2004 Sep; 70(3):227-31. PubMed ID: 15325892
    [Abstract] [Full Text] [Related]

  • 2. A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol II.
    Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM, Bax R.
    Contraception; 2004 Sep; 70(3):233-40. PubMed ID: 15325893
    [Abstract] [Full Text] [Related]

  • 3. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK, Baker JM, Barr SP, Johanson WM, Archer DF.
    Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
    [Abstract] [Full Text] [Related]

  • 4. Male tolerance study of 1% C31G.
    Mauck CK, Frezieres RG, Walsh TL, Schmitz SW, Callahan MM, Bax R.
    Contraception; 2004 Sep; 70(3):221-5. PubMed ID: 15325891
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of Femcap used with and without spermicide. Postcoital testing.
    Mauck CK, Baker JM, Barr SP, Johanson W, Archer DF.
    Contraception; 1997 Aug; 56(2):111-5. PubMed ID: 9315420
    [Abstract] [Full Text] [Related]

  • 6. SILCS diaphragm: postcoital testing of a new single-size contraceptive device.
    Schwartz JL, Ballagh SA, Creinin MD, Rountree RW, Kilbourne-Brook M, Mauck CK, Callahan MM.
    Contraception; 2008 Sep; 78(3):237-44. PubMed ID: 18692615
    [Abstract] [Full Text] [Related]

  • 7. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D.
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.
    Thompson KA, Malamud D, Storey BT.
    Contraception; 1996 May; 53(5):313-8. PubMed ID: 8724622
    [Abstract] [Full Text] [Related]

  • 9. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
    Mauck CK, Baker JM, Barr SP, Abercrombie TJ, Archer DF.
    Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
    [Abstract] [Full Text] [Related]

  • 10. Safety of single daily use for one week of C31G HEC gel in women.
    Ballagh SA, Baker JM, Henry DM, Archer DF.
    Contraception; 2002 Nov; 66(5):369-75. PubMed ID: 12443969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E, Perdigão A, Souza MH, Mauck C, Waller D, Zaneveld L, Faúndes A.
    Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial.
    Burke AE, Barnhart K, Jensen JT, Creinin MD, Walsh TL, Wan LS, Westhoff C, Thomas M, Archer D, Wu H, Liu J, Schlaff W, Carr BR, Blithe D.
    Obstet Gynecol; 2010 Dec; 116(6):1265-1273. PubMed ID: 21099590
    [Abstract] [Full Text] [Related]

  • 17. A non-antibiotic antimicrobial mixture (C31G): evaluation of the antimicrobial efficiency of C31G on vaginal cultures.
    Calis S, Yulug N, Sumnu M, Ayhan A, Hincal AA.
    Boll Chim Farm; 1992 Oct; 131(9):335-8. PubMed ID: 1492969
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Thurman AR, Moench TR, Hoke M, Politch JA, Cabral H, Mausser E, Nador E, Morton J, Hamorsky K, Swope K, Bratcher B, Anderson DJ, Whaley KJ.
    Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.